Fluoreszenz-Lebensdauer-Bildgebung der PolyQ-Proteinaggregation in Caenorhabditis elegans-Neuronen
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 5:36 min • June 17th, 2025
Loading...
Überblick
Diese Studie untersucht die Rolle von Chaperon-Proteinen bei der Aggregation von fehlgefalteten PolyQ-Proteinen in Caenorhabditis elegans. Mithilfe der Fluoreszenzlebensdauer-Bildgebungsmikroskopie (FLIM) werden die Unterschiede in der Fluoreszenzlebensdauer zwischen Kontroll- und Chaperon-defizienten Würmern analysiert, um die PolyQ-Aggregation zu visualisieren.
Wichtige Studienkomponenten
Wissenschaftsbereich
- Neurowissenschaften
- Zellbiologie
- Bildgebungstechniken
Hintergrund
- PolyQ-Proteine neigen zu Fehlfaltung und Aggregation.
- Chaperon-Proteine helfen, Aggregation in Neuronen zu verhindern.
- FLIM ist eine Technik zur Messung der Fluoreszenzlebensdauer.
- Das Verständnis der Proteinaggregation ist entscheidend für die Forschung zu neurodegenerativen Erkrankungen.
Zweck der Studie
- Um die Auswirkungen des Chaperon-Mangels auf die PolyQ-Aggregation zu bewerten.
- Um FLIM für die Visualisierung und Quantifizierung der Proteinaggregation zu nutzen.
- Um die Fluoreszenzlebensdauer zwischen Kontroll- und Chaperon-defizienten Würmern zu vergleichen.
Verwendete Methoden
- Präparation von C. elegans, die fluorophor-markierte PolyQ-Proteine exprimieren.
- Verwendung der konfokalen Mikroskopie für FLIM-Analyse.
- Messung der Fluoreszenzlebensdauer zur Bewertung der Aggregationsniveaus.
- Datenverarbeitung und -analyse mit FLIM-Software.
Hauptergebnisse
- Chaperon-defiziente Würmer zeigten eine reduzierte Fluoreszenzlebensdauer.
- Erhöhte PolyQ-Aggregation wurde bei Chaperon-defizienten Würmern beobachtet.
- FLIM-Farbcodierte Karten visualisierten effektiv Aggregationsmuster.
- Statistische Analyse bestätigte signifikante Unterschiede zwischen den Gruppen.
Schlussfolgerungen
- Chaperon-Proteine spielen eine kritische Rolle bei der Verhinderung der PolyQ-Aggregation.
- FLIM ist ein wertvolles Werkzeug zur Untersuchung der Proteinaggregation in lebenden Organismen.
- Die Ergebnisse tragen zum Verständnis der Mechanismen der Neurodegeneration bei.
Häufig gestellte Fragen
Was ist die Bedeutung der PolyQ-Aggregation?
PolyQ-Aggregation ist mit verschiedenen neurodegenerativen Erkrankungen verbunden und stellt daher einen wichtigen Forschungsbereich dar.
Wie funktioniert FLIM?
FLIM misst die Zeit, die ein Fluorophor im angeregten Zustand verbringt, und liefert so Einblicke in molekulare Wechselwirkungen.
Was sind Chaperon-Proteine?
Chaperon-Proteine unterstützen das korrekte Falten anderer Proteine und verhindern Aggregation.
Warum C. elegans für diese Studie verwenden?
C. elegans ist ein Modellorganismus, der genetische Manipulationen und die Beobachtung neuronaler Prozesse ermöglicht.
Was waren die Hauptergebnisse der Studie?
Die Studie ergab, dass Chaperon-Mangel zu erhöhter PolyQ-Aggregation führt, wie durch reduzierte Fluoreszenzlebensdauer belegt wird.
Wie kann diese Forschung das Verständnis neurodegenerativer Erkrankungen beeinflussen?
Durch die Aufklärung der Rolle von Chaperonen bei der Proteinaggregation kann diese Forschung therapeutische Strategien für neurodegenerative Erkrankungen beeinflussen.
Executive Industry Relevance
Fluorescence Lifetime Imaging Microscopy (FLIM) enables quantitative assessment of protein aggregation in live neurons, providing a mechanistic readout for target validation in neurodegenerative disease models. By detecting energy transfer between clustered fluorophores in polyQ aggregates, FLIM delivers functional evidence of pathological states that supports early-stage hypothesis testing and de-risking of therapeutic targets. This approach enhances predictive confidence in preclinical programs by linking molecular interactions to phenotypic outcomes in a disease-relevant system.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by measuring fluorescence lifetime changes that report on polyQ aggregation states in neurons.
- Operational Value: Enables biological de-risking through direct visualization of aggregation differences between control and chaperone-deficient conditions.
- Predictive Value: Supports portfolio triage by providing quantitative, imaging-based evidence of target engagement and pathway modulation.
Screening & Assay Development
- Assay Readiness: Prepares validated neuronal systems for downstream screening by establishing baseline fluorescence lifetime metrics in wild-type and disease-model worms.
- Quantitative Output: Generates color-coded lifetime maps that serve as standardized, reproducible readouts for compound-induced changes in aggregation.
- Screening Scalability: Supports platform reuse across genetic backgrounds and treatment conditions through standardized acquisition and analysis protocols.
Translational & Preclinical Research
- Disease Relevance: Models polyQ-dependent aggregation in C. elegans neurons, a system with translational fidelity to human neurodegenerative pathways.
- Mechanistic Continuity: Bridges discovery and preclinical validation by offering a consistent, quantitative method to track aggregation across experimental groups.
- Risk-Adjusted Decisions: Informs advancement criteria by identifying conditions where chaperone loss exacerbates aggregation, enabling target prioritization.
Pipeline & Workflow Integration
FLIM fits within the discovery continuum from target hypothesis testing through lead identification to preclinical validation, offering a reusable imaging modality for neurodegenerative disease programs.
- Discovery Biology: Supports hypothesis testing by measuring fluorescence lifetime as a functional readout of protein misfolding and aggregation in neurons.
- Screening: Delivers assay readiness through standardized lifetime measurements that detect aggregation changes in response to genetic or pharmacological perturbations.
- Analytics: Provides quantitative tau values and decay curve fitting that enable objective comparison of aggregation states across conditions.
- Translational Research: Connects to preclinical continuity by maintaining consistent readouts from worm neurons to mammalian models via shared FLIM-based quantification.
- Enterprise Reuse: Functions as a platform capability applicable to multiple proteinopathy targets beyond polyQ, including tau, alpha-synuclein, and TDP-43.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in protein aggregation assays through lifetime-based discrimination of molecular environments.
- Operational Value: Ensures standardization and reproducibility via photon-counting thresholds, IRF correction, and global fitting procedures detailed in the acquisition workflow.
- Strategic Value: Improves go/no-go decisions by delivering quantitative, imaging-based evidence that reduces reliance on endpoint assays and supports early biological validation.
- Portfolio Impact: Enables risk-adjusted prioritization by identifying modifiers of aggregation that can be progressed with higher confidence in target modulation.
Implementation Considerations
- Requires expertise in fluorescence lifetime theory, confocal microscopy, and FLIM data analysis to avoid artifacts such as photon pileup and poor decay fitting.
- Dependent on pulsed laser sources, time-correlated single photon counting (TCSPC) hardware, and FLIM software capable of multi-exponential fitting and IRF correction.
- Necessitates cross-team standardization of acquisition parameters including scan speed, photon thresholds, and region-of-interest selection to ensure data comparability.
- Involves adaptation considerations when transferring from C. elegans neurons to mammalian cell cultures or tissue sections due to differences in autofluorescence and scattering.
- Limited by the need for fluorophore tagging and potential perturbation of native protein behavior, which must be validated for each target of interest.
Biopharma FAQs
Why does fluorescence lifetime matter for target validation in polyQ models?
Fluorescence lifetime reports on the local molecular environment of fluorophores, decreasing when energy transfer occurs between clustered polyQ aggregates. This change provides a quantitative, mechanism-based readout that distinguishes aggregated from soluble states in neurons. It supports target validation by offering a functional assay that correlates with pathological burden in a disease-relevant system.
How does isolating the independent variable (chaperone deficiency) improve discovery pipeline decisions?
By comparing isogenic worms differing only in chaperone expression, the assay isolates the effect of a single genetic variable on polyQ aggregation. This enables clear attribution of lifetime changes to chaperone loss rather than genetic background noise. Such isolation increases confidence in target mechanism and supports rational progression of modifiers in the discovery pipeline.
What quantitative dependent variable measurements does FLIM enable for aggregation assessment?
FLIM provides fluorescence lifetime (tau) values derived from photon arrival time histograms, reflecting the average time fluorophores spend in the excited state. These values are reduced in chaperone-deficient worms due to energy transfer in aggregates, offering a continuous, quantitative metric. The technique also generates color-coded lifetime maps and decay curves for spatial and kinetic analysis of aggregation.
Why do replication requirements matter for cross-functional collaboration in FLIM-based studies?
Replication across biological repeats and imaging sessions ensures that observed lifetime differences are robust and not due to technical variability. The protocol recommends loading all samples from one condition, even if acquired separately, to support statistical validity. This practice enables reliable data sharing between biology, imaging, and analytics teams for consistent interpretation.
What statistical analysis capabilities are required before implementing FLIM for aggregation studies?
Implementation requires the ability to perform weighted mean lifetime calculation and assess chi-square goodness of fit, aiming for values close to one to confirm reliable decay modeling. The software must support global fitting, IRF correction, and exclusion of dim or saturated pixels via threshold settings. These capabilities ensure that lifetime measurements are accurate, reproducible, and suitable for comparative statistical analysis.
10:04
Imaging-Amyloid Gewebe gebeizt mit lumineszierenden konjugierte Oligothiophenes von hyperspektralen konfokalen Mikroskopie und Fluoreszenz Lifetime Imaging
Related Videos
0 Views
08:55
Visualisierung von intrazellulären SNARE Menschenhandel durch Fluoreszenz Lifetime Imaging Microscopy
Related Videos
0 Views
09:23
Wirkung von fluoreszierenden Proteinen auf Fusion Partner mit Trinukleotiderkrankungen Toxizität Assays in Hefe
Related Videos
0 Views
12:22
Automatisierte Quantifizierung der Fluoreszenz-in Synaptic C elegans
Related Videos
0 Views
03:03
Fluoreszierender Reporter-basierter Lähmungsassay: Eine Technik zur Beurteilung der altersassoziierten progressiven Bildung von Polyglutamin-Fluoreszenz-Reportern und der damit verbundenen Lähmung bei Caenorhabditis elegans
Related Videos
0 Views
03:11
Zeitraffer-Bildgebung zur Überwachung der transzellulären Ausbreitung prionenähnlicher Proteine in transgenen Nematoden
Related Videos
0 Views
07:51
Agarose Mikrokammern für Langzeit Calcium Imaging von Caenorhabditis elegans
Related Videos
0 Views
09:36
Erkennung von Protein subzelluläre Lokalisation durch grüne Fluoreszenz Protein Tagging und 4', 6-Diamidino-2-Phenylindole Färbung in Caenorhabditis elegans
Related Videos
0 Views
09:31
Charakterisierung von Amyloidstrukturen im Altern C. Elegans mit Fluoreszenz-Lebensdauer-Bildgebung
Related Videos
0 Views
09:18
Quantifizierung des gewebespezifischen proteostatischen Rückgangs bei Caenorhabditis elegans
Related Videos
0 Views
Last updated: 1 August 2026